Terazosin is a medication used in the management and treatment of benign prostatic hyperplasia and essential hypertension. Terazosin is a long-acting, selective alpha-1 adrenergic receptor antagonist. This activity reviews the indications, action, and contraindications for Terazosin as a valuable agent in managing benign prostatic hyperplasia, essential hypertension, and nephrolithiasis.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/42967
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABTS - 1.0 Point; Credit Type(s): Accredited CME (ABTS)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABTS - 1.0 Point; Credit Type(s): Self-Assessment (ABTS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Ambulatory/Outpatient, Cardiothoracic, Cardiovascular, Cardiovascular Disease, Chemical Pathology, General Operative Anesthesia, General Surgery, Geriatric Medicine, Internal Medicine, Medical Oncology, Nephrology
Subscribe
Login
0 Comments
Oldest